Biosimilar manufacture is a complex, multistep process, carefully designed and closely monitored to ensure the end result is a high-quality product.1 For each biosimilar, an individualized manufacturing method, cell culture, purification process and system of analytical checks is developed.1
- Kabir ER, et al. The breakthrough of biosimilars: A twist in the narrative of biological therapy. Biomolecules. 2019;9(9):410.
- Vulto AG, et al. The process defines the product: what really matters in biosimilar design and production? Rheumatology (Oxford). 2017;56(suppl_4):iv14-iv29.
- Gupta SK, et al. http://www.bioprocessintl.com/
manufacturing/biosimilars/opportunities-challenges-biosimilar-development. Published 2017. Accessed May 5, 2021.
- Al-Sabbagh A, et al. Development of biosimilars. Semin Arthritis Rheum. 2016; 45(5 suppl):S11–S18.